NO20030239L - Modifisert virus - Google Patents
Modifisert virusInfo
- Publication number
- NO20030239L NO20030239L NO20030239A NO20030239A NO20030239L NO 20030239 L NO20030239 L NO 20030239L NO 20030239 A NO20030239 A NO 20030239A NO 20030239 A NO20030239 A NO 20030239A NO 20030239 L NO20030239 L NO 20030239L
- Authority
- NO
- Norway
- Prior art keywords
- modified virus
- virus
- modified
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10345—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/40—Vectors comprising a peptide as targeting moiety, e.g. a synthetic peptide, from undefined source
- C12N2810/405—Vectors comprising RGD peptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/55—Vectors comprising as targeting moiety peptide derived from defined protein from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6009—Vectors comprising as targeting moiety peptide derived from defined protein from viruses dsDNA viruses
- C12N2810/6018—Adenoviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
- C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
- C12N2810/851—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from growth factors; from growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/80—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates
- C12N2810/85—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian
- C12N2810/859—Vectors comprising as targeting moiety peptide derived from defined protein from vertebrates mammalian from immunoglobulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0017720.4A GB0017720D0 (en) | 2000-07-19 | 2000-07-19 | Modified virus |
| PCT/GB2001/003252 WO2002008263A2 (en) | 2000-07-19 | 2001-07-19 | Modified virus having an altered tropism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030239D0 NO20030239D0 (no) | 2003-01-17 |
| NO20030239L true NO20030239L (no) | 2003-03-18 |
Family
ID=9895953
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030239A NO20030239L (no) | 2000-07-19 | 2003-01-17 | Modifisert virus |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7456008B2 (xx) |
| EP (1) | EP1301613A2 (xx) |
| JP (1) | JP2004504062A (xx) |
| CN (1) | CN1443243A (xx) |
| AU (2) | AU2001270879B2 (xx) |
| BR (1) | BR0112624A (xx) |
| CA (1) | CA2413851A1 (xx) |
| CZ (1) | CZ2003152A3 (xx) |
| GB (1) | GB0017720D0 (xx) |
| IL (1) | IL153879A0 (xx) |
| MX (1) | MXPA03000449A (xx) |
| NO (1) | NO20030239L (xx) |
| NZ (1) | NZ524251A (xx) |
| PL (1) | PL360350A1 (xx) |
| WO (1) | WO2002008263A2 (xx) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040077081A1 (en) | 2001-02-07 | 2004-04-22 | Egbert Oosterwijk | Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| DK1358318T3 (da) * | 2001-02-07 | 2007-01-02 | Wilex Ag | Hybridomcellelinje G250 og dens anvendelse til frembringelse af monoklonale antistoffer |
| JP5408833B2 (ja) | 2002-07-01 | 2014-02-05 | ヴィレックス アクチェンゲゼルシャフト | 腎細胞腫を治療するためのＣＧ２５０およびＩＬ−２またはＩＦＮ−αを含有する抗腫瘍剤 |
| SE0301936D0 (sv) * | 2003-06-30 | 2003-06-30 | Affibody Ab | New polypeptide |
| US7993650B2 (en) | 2003-07-04 | 2011-08-09 | Affibody Ab | Polypeptides having binding affinity for HER2 |
| SE0301987D0 (sv) * | 2003-07-04 | 2003-07-04 | Affibody Ab | New polypeptide |
| US20070275873A1 (en) * | 2004-04-29 | 2007-11-29 | Heidner Hans W | Methods and Compositions Comprising Protein L Immunoglobulin Binding Domains for Cell-Specific Targeting |
| AU2005310604A1 (en) * | 2004-11-30 | 2006-06-08 | Kiim Pharm Lab. Inc. | Anti-HIV drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-HIV drug |
| US8221998B2 (en) | 2005-05-20 | 2012-07-17 | Glaxosmithkline Llc | Expression of protein GB1 domain fusion proteins in mammalian cells |
| GB0524788D0 (en) | 2005-12-05 | 2006-01-11 | Affibody Ab | Polypeptides |
| WO2014055771A1 (en) * | 2012-10-05 | 2014-04-10 | The Trustees Of The University Of Pennsylvania | Human alpha-folate receptor chimeric antigen receptor |
| AU2014236207B2 (en) | 2013-03-14 | 2019-05-23 | Salk Institute For Biological Studies | Oncolytic adenovirus compositions |
| EP2940128A1 (en) | 2014-04-30 | 2015-11-04 | Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) | Adenovirus comprising an albumin-binding moiety |
| EP3072900A1 (en) * | 2015-03-27 | 2016-09-28 | Medizinische Hochschule Hannover | Anti-tumour medicament based on adenovirus |
| WO2017147265A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | High throughput assay for measuring adenovirus replication kinetics |
| CA3013639A1 (en) | 2016-02-23 | 2017-08-31 | Salk Institute For Biological Studies | Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics |
| CA3045892A1 (en) | 2016-12-12 | 2018-06-21 | Salk Institute For Biological Studies | Tumor-targeting synthetic adenoviruses and uses thereof |
| CN110590939B (zh) * | 2019-09-20 | 2024-02-02 | 广州暨南大学医药生物技术研究开发中心有限公司 | 一种利用基因工程获得重组人纤连蛋白的方法 |
| CN114761030A (zh) * | 2019-11-01 | 2022-07-15 | 休斯敦系统大学 | 具有诱导的抗肿瘤免疫的溶瘤病毒疗法 |
| CN116334010B (zh) * | 2023-05-30 | 2023-08-29 | 中义(北京)健康研究院 | 一种重组单纯疱疹病毒及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9223084D0 (en) * | 1992-11-04 | 1992-12-16 | Imp Cancer Res Tech | Compounds to target cells |
| SE9400088D0 (sv) * | 1994-01-14 | 1994-01-14 | Kabi Pharmacia Ab | Bacterial receptor structures |
| US5846782A (en) * | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
| BR9612685A (pt) * | 1995-11-28 | 1999-07-20 | Genvec Inc | Vetores e métodos para transferéncia de gene para células |
| HUP0002070A2 (hu) | 1997-05-28 | 2000-10-28 | Genvec, Inc. | Alternatív módon célba juttatott adenovírus |
| IL137730A0 (en) * | 1998-02-17 | 2001-10-31 | Uab Research Foundation | Modified adenovirus containing a fiber replacement protein |
| CN1257286C (zh) | 1998-08-27 | 2006-05-24 | 森泰莱昂公司 | 用于递送异源基因的定向腺病毒载体 |
| JP2002525065A (ja) * | 1998-09-11 | 2002-08-13 | ジェンベク、インコーポレイティッド | 選択的にターゲッティングされるアデノウイルス |
| AU763733B2 (en) * | 1999-07-06 | 2003-07-31 | Got-A-Gene Ab | Recombinant adenovirus |
-
2000
- 2000-07-19 GB GBGB0017720.4A patent/GB0017720D0/en not_active Ceased
-
2001
- 2001-07-19 US US10/333,235 patent/US7456008B2/en not_active Expired - Fee Related
- 2001-07-19 IL IL15387901A patent/IL153879A0/xx unknown
- 2001-07-19 JP JP2002514167A patent/JP2004504062A/ja active Pending
- 2001-07-19 MX MXPA03000449A patent/MXPA03000449A/es not_active Application Discontinuation
- 2001-07-19 AU AU2001270879A patent/AU2001270879B2/en not_active Ceased
- 2001-07-19 BR BR0112624-5A patent/BR0112624A/pt not_active IP Right Cessation
- 2001-07-19 CN CN01812995A patent/CN1443243A/zh active Pending
- 2001-07-19 AU AU7087901A patent/AU7087901A/xx active Pending
- 2001-07-19 WO PCT/GB2001/003252 patent/WO2002008263A2/en active IP Right Grant
- 2001-07-19 PL PL36035001A patent/PL360350A1/xx unknown
- 2001-07-19 CZ CZ2003152A patent/CZ2003152A3/cs unknown
- 2001-07-19 EP EP01949764A patent/EP1301613A2/en not_active Withdrawn
- 2001-07-19 CA CA002413851A patent/CA2413851A1/en not_active Abandoned
- 2001-07-19 NZ NZ524251A patent/NZ524251A/en unknown
-
2003
- 2003-01-17 NO NO20030239A patent/NO20030239L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001270879B2 (en) | 2007-09-20 |
| US7456008B2 (en) | 2008-11-25 |
| CN1443243A (zh) | 2003-09-17 |
| CZ2003152A3 (cs) | 2003-05-14 |
| WO2002008263A2 (en) | 2002-01-31 |
| MXPA03000449A (es) | 2004-12-13 |
| AU7087901A (en) | 2002-02-05 |
| NO20030239D0 (no) | 2003-01-17 |
| CA2413851A1 (en) | 2002-01-31 |
| IL153879A0 (en) | 2003-07-31 |
| JP2004504062A (ja) | 2004-02-12 |
| WO2002008263A3 (en) | 2002-06-13 |
| NZ524251A (en) | 2004-07-30 |
| PL360350A1 (en) | 2004-09-06 |
| EP1301613A2 (en) | 2003-04-16 |
| GB0017720D0 (en) | 2000-09-06 |
| US20040132007A1 (en) | 2004-07-08 |
| BR0112624A (pt) | 2003-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE290000T1 (de) | Muscarinagonisten | |
| ATE252099T1 (de) | Biarylcarboxamide | |
| DE10136334B8 (de) | Hochgeschwindigkeitsvertikalresonatoroberflächenemissionslaser | |
| ATA2932001A (de) | Schneefräse | |
| NO20030239L (no) | Modifisert virus | |
| DE50100710D1 (de) | Wischblatt | |
| ATE262530T1 (de) | Indolochinazolinone | |
| NO20030276L (no) | Fremgangsmåte | |
| DE10192638T1 (de) | Bohrstangenladevorrichtung | |
| AR028336A1 (es) | 4-hidroxi-tetrahidropiridonas fenilsubstituidas | |
| DE60130851D1 (de) | Turboladersteuereinrichting | |
| ATE509008T1 (de) | Sulfonylguanidine | |
| DE10196064T1 (de) | Halbleiterfotodektionsgerät | |
| DE50100817D1 (de) | Kugelgelenk | |
| DE50011511D1 (de) | Blowby-Heizung | |
| AR028061A1 (es) | 2-enamino-cetonitrilos fenil-substituidos | |
| AR027931A1 (es) | Antitranspirantes | |
| DE10052925B4 (de) | Schaukelbett | |
| ATE476423T1 (de) | Benzoylpyridazine | |
| DE50007634D1 (de) | Kardioplegieballonkatheter | |
| DE10085445T1 (de) | Drahterodierbearbeitungseinrichtung | |
| DE10195909T1 (de) | Viehfüttervorrichtung | |
| AR027982A1 (es) | Aril- y heteroarilsulfonatos | |
| DE10195992T1 (de) | Oberflächenendbearbeitungsbelag | |
| ATE284887T1 (de) | Thienopyrrolidinone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |